3.Hoell, JI et al. (2017) End-of-life care in children with haematological malignancies. Oncotarget 8, 89939–89948.
4.Mousavi, SM, Pourfeizi, A and Dastgiri, S (2010) Childhood cancer in Iran. Childhood cancer in Iran. Journal of Pediatric Hematology/Oncology 32, 376–382.
5.de Martel, C et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. The Lancet Oncology 13, 607–615.
6.Torres, HA et al. (2017) The oncologic burden of hepatitis c virus infection: a clinical perspective. CA: A Cancer Journal for Clinicians 67, 411–431.
7.Machicado, C and Marcos, LA (2016) Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: a systematic review. International Journal of Cancer 138, 2915–2921.
8.Benamrouz, S et al. (2012) Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa). Parasite 19, 101–115.
9.Bayani, M et al. (2013) The prevalence of Toxoplasma gondii in hemodialysis patients. Iranian Red Crescent Medical Journal 15, e5225. doi: 10.5812/ircmj.5225.
10.Dubey, J and Jones, J (2008) Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology 38, 1257–1278.
11.Daryani, A et al. (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Tropica 137, 185–194.
12.Saadatnia, G et al. (2012) A review on human toxoplasmosis. Scandinavian Journal of Infectious Diseases 44, 805–814.
13.Yazar, S et al. (2004) Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. Journal of Medical Microbiology 53, 1183–1186.
14.Chintakuntlawar, A et al. (2015) Toxoplasmosis in patients with haematological malignancies. Leukemia & Lymphoma 56, 536–538.
15.Cong, W et al. (2015) Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Letters 359, 307–313.
16.Wang, L et al. (2015) Seroprevalence and genetic characterization of Toxoplasma gondii in cancer patients in Anhui Province, Eastern China. Parasites & Vectors 8, 162.
17.Thomas, F et al. (2012) Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biology Letter 8, 101–103.
18.Kalantari, N et al. (2017) Detection of Toxoplasma gondii DNA in malignant breast tissues in breast cancer patients. International Journal of Molecular and Cellular Medicine 6, 91–96.
19.Shen, DF et al. (2001) Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Modern Pathology 14, 995–999.
20.Saki, J, Tavakoli, S and Pedram, M (2017) Seroprevalence and molecular evaluation of toxoplasmosis in children with cancer in Khuzestan province, Southwest of Iran. Journal of Parasitic Diseases 41, 947–951.
21.Huang, Y et al. (2016) Is Toxoplasma gondii infection a risk factor for leukemia? An evidence-based meta-analysis. Medical Science Monitor 22, 1547–1552.
22.Wang, ZD et al. (2017) Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Frontiers in Microbiology 8, 389. doi: 10.3389/fmicb.2017.00389.
23.Bhadra, R and Khan, IA (2012) Redefining chronic toxoplasmosis-a T cell exhaustion perspective. PLoS Pathogens 8, e1002903. doi: 10.1371/journal.ppat.1002903.
24.Lambert, H, Dellacasa-Lindberg, I and Barragan, A (2011) Migratory responses of leukocytes infected with Toxoplasma gondii. Microbes Infection 13, 96–102.
25.Gharavi, MJ, Roozbehani, M and Mandeh, Z (2017) Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients. Veterinary World 10, 1063–1065.
26.Kalantari, N et al. (2015) Preliminary study on association between toxoplasmosis and breast cancer in Iran. Asian Pacific Journal of Tropical Biomedicine 5, 44–47.
27.Mizani, A et al. (2017) Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Tropical Medicine and Health 45, 7.
28.Elsheikha, H (2008) Congenital toxoplasmosis: priorities for further health promotion action. Public Health 122, 335–353.
29.Nowakowska, D et al. (2014) Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012. Epidemiology & Infection 142, 656–661.
30.Nimir, A et al. (2010) Latent toxoplasmosis in patients with different malignancy: a hospital based study. Journal of Clinical Medicine 2, 117–120.
31.Belluco, S et al. (2017) Toxoplasma gondii infection and food consumption: a systematic review and meta-analysis of case-controlled studies. Critical Reviews in Food Science and Nutrition 11, 1–12.
32.Vogel, CL and Lunde, MN (1969) Toxoplasma serology in patients with malignant diseases of the reticuloendothelial system. Cancer 23, 614–618.
33.Ghasemian, M et al. (2007) Determination of antibodies (IgG, IgM) against Toxoplasma gondii in patients with cancer. Iranian Journal of Parasitology 2, 1–6.
34.Su, C et al. (2010) Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii. Parasitology 137, 1–11.
35.Abolghasemi, H et al. (2016) Central nervous system toxoplasmosis in relapsed Hodgkin's lymphoma: a case report. Iranian Journal of Cancer Prevention 9, e5810. doi: 10.1097/MD.0000000000005810.